Skip to main content

and
  1. Article

    Open Access

    Safety and efficacy of interrupting dual antiplatelet therapy one month following percutaneous coronary intervention: a meta-analysis of randomized controlled trials

    Very short duration of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) has recently attracted a lot of attention with the introduction of newer generations stents. This is a...

    Shane Parfrey, Amr Abdelrahman, Daniel Blackman in BMC Cardiovascular Disorders (2022)